Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

CSX slides more than 7% on worries over CEO Harrison's health

Published 12/15/2017, 04:36 PM
Updated 12/15/2017, 04:36 PM
© Reuters.  CSX slides more than 7% on worries over CEO Harrison's health
  • CSX Corp. (NYSE:CSX) fell 7.6% in today's trade on worries that CEO Hunter Harrison may not return to the company after being placed on medical leave, while some investors and governance experts called on the company to disclose more about Harrison’s health condition.
  • Citi analyst Christian Wetherbee recommends using today's CSX selloff as a buying opportunity saying most of what needed to be done to turn around the railroad already has been done, and CSX was in better shape than Canadian Pacific when Harrison took over in 2012; he keeps a Buy rating on the stock with a $58 price target.
  • But Loop Capital's Rick Paterson thinks the appointment of Jim Foote as interim CEO is an "ominous sign" and implies Harrison's return is "less than likely," adding that he sees CSX's future as "very cloudy" if Harrison does not return since the CEO likely has not had enough time to successfully change the company's network and culture; he rates the stock as a Hold with a $57 price target.
  • Now read: Top 10 Industrial Stocks For Dividend Growth And Income


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.